Floatz logo

PREDNISONE TABLETS

Leukemia, B-Cell

Children's Oncology GroupSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Leukemia, B-Cell cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
St. Jude Children's Research Hospital
Phase 2BB
PEGASPARGASE
Children's Oncology Group
Phase 2B
Solu-Cortef
Children's Oncology Group
Phase 2B
Cyclophosphamide
Dana-Farber Cancer Institute
Phase 2B
METHOTREXATE
Children's Oncology Group
Phase 2B

View all 22 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →